protagenic  technology  protagenic therapeutics inc pt activity in brain cells a novel neuropeptide platform with promising therapeutic applications   we have created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders the lead product candidate pt is targeted to inhibit anxiety and depression without interfering with normal brain function   leveraging activity impacting multiple neuropathological processes protagenic is reaching beyond the boundaries of traditional therapeutics for anxiety and depression by focusing on restoring the body’s natural equilibrium   through  years of accumulated research protagenic therapeutics scientists are characterizing the actions of neuropeptides from the genetic level through systemic biological changes to characterize changes to the organisms’ physiology and behavior   the potential to improve mental health by restoring the health of neuronal cells and cellular system represents an exciting paradigm shift in treatment approaches our technology in numbers amino acids in lengthmillion years of molecular conservationmajor human disease targetsyears of development at protagenic therapeutics inc recent studies report an important relationship between mood disorders and disturbances in neuropeptide circuits of the brain therapeutics that target the natural neuropeptide circuits that are responsible for restoring normal emotionality may offer effective and safe new treatment options protagenic  protagenic therapeutics inc​  treatment of mood and anxiety disorders​ neuroactive peptides technology the team meet us the science pipeline development technology protagenic therapeutics inc firstinclass neuropeptides the mission to provide innovative safe and effective treatments for anxiety and depression by using neuropeptide hormones to restore normal emotionality see more anxiety  depression our focus novel antianxiety and antidepression natural brain hormone pharmaceutical agents based on encouraging preclinical results see more a platform technology initial family of compounds tcap’s have the potential to become firstinclass pharmaceutical agents addressing a variety of unmet clinical needs see more innovative safe and effective treatments for anxiety and depression by using neuropeptide hormones to restore normal emotionality protagenic therapeutics inc  th ave new york ny laboratoriespharmaceutical  mapquest protagenic therapeutics inc  th ave new york ny  reviews   website menu  reservations make reservations order online tickets tickets see availability nearby directions  date name shares transaction value  khalil barrage director    award at  per share   garo h armen see remarks director    acquisition at  per share   garo h armen see remarks director    award at  per share   khalil barrage director    award at  per share   robert b stein director    award at  per share   gregory h ekizian director    award at  per share   alexander k arrow chief financial officer    award at  per share   joshua n silverman director    award at  per share  newslatestcompanyusptix marketwatch news on ptix no news currently available for ptix newsnonmarketwatchcompanyusptix other news on ptix q protagenic therapeutics incnew  pm may    edgar online  edg  q k ka protagenic therapeutics incnew  am may    edgar online  edg  q k k protagenic therapeutics incnew  am april    edgar online  edg  q k q protagenic therapeutics incnew  pm nov    edgar online  edg  q k q protagenic therapeutics incnew  pm aug    edgar online  edg  q k q protagenic therapeutics incnew  am july    edgar online  edg  q k winning and losing stocks in the technology sector for the week ending dec nd  am dec    wall st cheat sheet money making strategies on stocks poised to triple  am nov    seeking alpha stock analysis recap heres why these stocks trended this week  pm sept    wall st cheat sheet  super hot stocks lighting up our trading screens azo ccl kona cag fds hls xlnx jef atrn hme  pm sept    wall st cheat sheet a review of stocks that are poised to triple  am aug    seeking alpha top buy and sell ideas based on mondays biggest gainers  part   am july    seeking alpha shares of atrinsic are poised to triple  am july    seeking alpha zillow valuation matters  pm july    seeking alpha facebook music will be a transformative event for streaming and mobile services  am june    seeking alpha pandoras ipo and the great sucking noise  pm june    seeking alpha is pandora worth  billion  pm june    seeking alpha crawford atrinsic biggest price gainers crda atrn  pm april    the wall street journal interactive edition china security  surveillance technology atrinsic biggest price gainers csr atrn  pm april    the wall street journal interactive edition should atrn spin off kazaa in an ipo  am march    seeking alpha loading more headlines at a glance protagenic therapeutics inc  th avenue suite  new york new york  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for ptix newspressreleasecompanyusptix press releases on ptix junxure expands leadership team adds timothy betts as chief information officer  am march    pr newswire  prf sparta capital ltd announces agreement to acquire supernova performance technologies ltd  pm jan    filing services canada trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pthis is what might be next for oj simpson after parole pweekend roundup companies that may cut dividends  faang stocks and market bubbles  enjoy london on the cheap pwhy you might want to avoid these  dividend stocks pattention shoppers ‘amazon effect’ is creating bargain stocks pas gdp will show us economy on same track pstocks brace for volatility in earnings deluge fed meeting looms adunkirk storms us box office with  million debut aoj simpson made over  while in prison and won’t have to give any of it to the goldman family aactor john heard ‘home alone’ dad dead at  amicrosoft rides huge tax benefit from failing at smartphones to big earnings beat aamazon’s foray into groceries means more mergers of food companies experts say ayogaworks ipo pulled on valuation concerns not market conditions aqualcomm’s issues go beyond apple fight apay tv expected to lose more than a million subscribers in latest quarter aexxon earnings will stock trade higher on expected secondquarter beat aalphabet earnings a  billion hit for google potential youtube results for investors achipotle earnings media coverage of the latest illness scare will put earnings targets at risk anolan’s cinematic vision in ‘dunkirk’ is hollywood’s best defense against netflix age earnings departing ceo immelt’s last chance to bring good things to investors abitcoin surges as miners avert split for now loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice    forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied protagenic therapeutics inc company profile  bloomberg feedback protagenic therapeutics inc public company company profile sector health care industry biotech  pharma subindustry biotech protagenic therapeutics inc operates as a biotechnology company the company focuses on the discovery and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders protagenic therapeutics offers its services in the united states corporate information address  th avenue suite  new york ny  united states phone  fax  web url wwwprotageniccom board members chairmancofounder company garo armen agenus inc board members company khalil barrage invus group llcthe show more from the web key executives garo h armen chairmancofounder alexander k arrow cfosecretary sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data atrn stock quote  protagenic therapeutics inc  bloomberg markets error could not add to watchlist x  watchlist protagenic therapeutics inc atrnus ticker change atrnus has changed to a new ticker symbol usd volume  before its here its on the bloomberg terminal learn more volume  current pe ratio ttm  earnings per share usd ttm  market cap usd  shares outstanding  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later there are currently no press releases for this ticker please check back later profile protagenic therapeutics inc operates as a biotechnology company the company focuses on the discovery and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders protagenic therapeutics offers its services in the united states address  th avenuesuite new york ny united states phone  website wwwprotageniccom executives board members garo h armen chairmancofounder alexander k arrow cfosecretary show more